270 related articles for article (PubMed ID: 31119614)
21. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.
Edwards JL; Apicella MA
Clin Microbiol Rev; 2004 Oct; 17(4):965-81, table of contents. PubMed ID: 15489357
[TBL] [Abstract][Full Text] [Related]
22. Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type.
Buchanan TM; Eschenbach DA; Knapp JS; Holmes KK
Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):978-80. PubMed ID: 6781350
[TBL] [Abstract][Full Text] [Related]
23. [Gonococcal surface antigens and their significance for serotyping and vaccines].
Kohl PK; Meyer TF; Petzoldt D
Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
[TBL] [Abstract][Full Text] [Related]
24. Use of Human Fallopian Tube Organ in Culture (FTOC) and Primary Fallopian Tube Epithelial Cells (FTEC) to Study the Biology of Neisseria gonorrhoeae Infection.
Álamos-Musre AS; Escobar A; Tapia CV; Christodoulides M; Rodas PI
Methods Mol Biol; 2019; 1997():377-402. PubMed ID: 31119635
[TBL] [Abstract][Full Text] [Related]
25. Gonococcal Defenses against Antimicrobial Activities of Neutrophils.
Palmer A; Criss AK
Trends Microbiol; 2018 Dec; 26(12):1022-1034. PubMed ID: 30115561
[TBL] [Abstract][Full Text] [Related]
26. Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers.
Schmidt KA; Schneider H; Lindstrom JA; Boslego JW; Warren RA; Van de Verg L; Deal CD; McClain JB; Griffiss JM
Sex Transm Dis; 2001 Oct; 28(10):555-64. PubMed ID: 11689753
[TBL] [Abstract][Full Text] [Related]
27. [Characteristic of biological properties of Neisseria gonorrhoeae and parameters of local immunity during urogenital gonococcal infection].
Mikhaĭlova OO; Chaĭnikova IN; Mikhaĭlova EA; Smoliagin AI
Zh Mikrobiol Epidemiol Immunobiol; 2009; (4):103-6. PubMed ID: 19718832
[TBL] [Abstract][Full Text] [Related]
28. Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae.
Gulati S; Rice PA; Ram S
Methods Mol Biol; 2019; 1997():267-280. PubMed ID: 31119629
[TBL] [Abstract][Full Text] [Related]
29. Development of a gonorrhoea vaccine: prospects, strategies and tactics.
Gotschlich EC
Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769
[TBL] [Abstract][Full Text] [Related]
30. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.
Plummer FA; Chubb H; Simonsen JN; Bosire M; Slaney L; Maclean I; Ndinya-Achola JO; Waiyaki P; Brunham RC
J Clin Invest; 1993 Jan; 91(1):339-43. PubMed ID: 8423230
[TBL] [Abstract][Full Text] [Related]
31. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.
Lewis LA; Ram S
FEBS Lett; 2020 Aug; 594(16):2670-2694. PubMed ID: 32058583
[TBL] [Abstract][Full Text] [Related]
32. Vaccine research for gonococcal infections: where are we?
Jerse AE; Deal CD
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.
Cornelissen CN
Future Microbiol; 2008 Jun; 3(3):287-98. PubMed ID: 18505395
[TBL] [Abstract][Full Text] [Related]
34. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
Gulati S; Zheng B; Reed GW; Su X; Cox AD; St Michael F; Stupak J; Lewis LA; Ram S; Rice PA
PLoS Pathog; 2013; 9(8):e1003559. PubMed ID: 24009500
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of two novel Neisseria gonorrhoeae virulent components: the macrophage infectivity potentiator and the outer membrane protein A.
Starnino S; Leuzzi R; Ghisetti V; De Francesco MA; Cusini M; Impara G; Galluppi E; Pizza M; Stefanelli P
New Microbiol; 2010 Apr; 33(2):167-70. PubMed ID: 20518279
[TBL] [Abstract][Full Text] [Related]
36. A pilus peptide vaccine for the prevention of gonorrhea.
Schoolnik GK; Tai JY; Gotschlich EC
Prog Allergy; 1983; 33():314-31. PubMed ID: 6187017
[No Abstract] [Full Text] [Related]
37. Neisseria gonorrhoeae physiology and pathogenesis.
Green LR; Cole J; Parga EFD; Shaw JG
Adv Microb Physiol; 2022; 80():35-83. PubMed ID: 35489793
[TBL] [Abstract][Full Text] [Related]
38. Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae.
Plante M; Jerse A; Hamel J; Couture F; Rioux CR; Brodeur BR; Martin D
J Infect Dis; 2000 Sep; 182(3):848-55. PubMed ID: 10950780
[TBL] [Abstract][Full Text] [Related]
39. Glycointeractome of Neisseria gonorrhoeae: Identification of Host Glycans Targeted by the Gonococcus To Facilitate Adherence to Cervical and Urethral Epithelial Cells.
Semchenko EA; Everest-Dass AV; Jen FE; Mubaiwa TD; Day CJ; Seib KL
mBio; 2019 Jul; 10(4):. PubMed ID: 31289181
[No Abstract] [Full Text] [Related]
40. Neisseria gonorrhoeae metalloprotease NGO1686 is required for full piliation, and piliation is required for resistance to H2O2- and neutrophil-mediated killing.
Stohl EA; Dale EM; Criss AK; Seifert HS
mBio; 2013 Jul; 4(4):. PubMed ID: 23839218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
